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ABSTRACT
Objectives: To examine prenatal vitamin (PNV) use between women who participate
in The Special Supplemental Nutrition Program for Women, Infants, and Children
(WIC) and pregnant women who do not participate in WIC. The secondary objective
is to explore associations between PNV use and sociodemographic characteristics of
pregnant women.
Methods: A cross-sectional study was conducted among a convenience sample of
Rhode Island pregnant women 18 years of age or older. Women were recruited from
WIC offices, OB-GYN offices, and pregnant women known to the research team. All
women that participated in the study completed an anonymous 21-question survey inperson or online that asked about PNV use, sociodemographic characteristics, and
food security. We conducted t-tests and chi-square tests in this data analysis using
SPSS. T-tests were used for continuous variables and chi-square was used for
categorical variables.
Results: Out of 96 pregnant women, 61% were WIC participants. WIC participants
were more likely to be Hispanic (47% vs 16%, p=0.002). Race significantly differed
between WIC and non-WIC groups (p=0.02). Approximately 35% of WIC participants
identified as a race other than white compared to 8% of non-WIC women. Education
levels significantly differed between groups (p<0.001) with 7% of WIC women with a
bachelor’s degree or above compared to 59% of non-WIC women. WIC participants
had a higher prevalence of food insecurity than non-WIC participants (56% vs 27%,
p=0.01). There was no significant difference in PNV use between WIC and non-WIC
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participants (p=0.91), with 92% of women from both groups consuming PNVs during
pregnancy. WIC participants were more likely to receive PNVs through a prescription
than non-WIC participants (53% vs 24%, p=0.003).
Conclusion: This study indicates that there is high use of prenatal vitamins in both
WIC and non-WIC Participants. In addition, we found that WIC participants are
obtaining prescription prenatal vitamins more than women that are not participating in
WIC. This is worth further attention as the composition of prescription and nonprescription prenatal vitamins differ.
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INTRODUCTION
Use of prenatal vitamins (PNVs) in pregnant women can improve maternal
nutrition status and decrease the risk of adverse birth outcomes such as preterm birth,
low birth weight, long-term cognitive development, cardiometabolic disease, and
mortality.1–3 Therefore, clinicians recommend PNVs to meet micronutrient
requirements during pregnancy.4
PNVs are a combination of vitamins and minerals that facilitate the process of
receiving adequate nutrition during pregnancy.5 Some populations may be at risk for
poor PNV use. Previous studies conducted about one decade ago show poor PNV use
among low-income women, African American women, or Hispanic women compared
to women that are higher-income and white.6,7 This study showed that PNV use was
higher in women who have higher education levels and also higher in women that are
married or in a domestic partnership compared to single or divorced women.6
The Special Supplemental Nutrition Program for Women, Infants, and Children
(WIC) is a federally funded supplemental nutrition program for low-income,
nutritionally at-risk pregnant women, breastfeeding women, non-breastfeeding
postpartum women, and children up to their 5th birthday.8\ This program is available in
all 50 states. The women in this program receive nutrition education, supplemental
food vouchers, information on the benefits of breastfeeding promotion and support,
and referrals to healthcare. The goal of WIC nutrition education services is to
strengthen nutrition education, adopt a more behavioral approach to nutrition
education, be client oriented, and focus on healthy behaviors for life.8 In order to
participate in this program, there is a strict income eligibility requirement based on the
2

number of participants in the household and annual, monthly, twice-monthly, and biweekly incomes. Women participating in WIC receive nutrition education, but it is not
required to educate about PNV intake, and women are not prescribed PNV through
WIC. Interestingly enough, there are no studies conducted on PNV use among WIC
participants. We are interested in examining the prevalence of women consuming any
type of PNV during pregnancy and whether PNV consumption differs between women
participating in WIC and women not participating in WIC in Rhode Island.
The Rhode Island Department of Health (DOH) conducts surveys every year on
1,900 randomly selected women who gave birth to a live infant in the past year called
the Pregnancy Risk Assessment Monitoring System (PRAMS) that determine daily
multivitamin (MVI) use 1 month prior to pregnancy.9 The survey asks how many
times women take a MVI, PNV, or folic acid supplement one month before they
conceived, while also measuring sociodemographic characteristics and WIC
participation. Mothers that were older than 30 years old, white (non-Hispanic),
married, having 12 or more years of education, having private health insurance, and
not participating in WIC were more likely to take a MVI one month prior to
pregnancy.9 Although Rhode Island collects data on these pregnant women that live in
Rhode Island, they do not measure actual PNV use during pregnancy.
Results from PRAMS found lower rates of MVI use prior to pregnancy among
WIC participants as compared to non-WIC participants.9 The purpose of this study is
to examine PNV use during pregnancy between WIC and non-WIC participants.
Because women participating in WIC are low income, they may be less likely to
consume PNVs due to their cost, which would be consistent with previous research
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showing that low-income women are less likely to consume PNVs.6 The possibility of
lower rates of PNV use among WIC participants could serve as a motivator for
communities and physicians to provide or supplement PNVs to help women meet their
daily micronutrient requirements during pregnancy.
The objective of this cross-sectional study was to assess PNV intake among
pregnant women in the state of Rhode Island and explore whether WIC participants
PNV use is similar to or different from pregnant women not participating in WIC. We
hypothesized that women participating in WIC were less likely to consume PNVs
compared to women that do not participate in WIC.
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METHODS
Study Design and Participants
We utilized a cross-sectional design to study PNV use among a convenience
sample of pregnant women. Our hypothesis is that women participating in WIC will
show less PNV intake compared to women that do not participate in WIC. Inclusion
criteria included pregnant women 18 years of age or older who are able to read
English or Spanish. Participants were recruited from Rhode Island WIC offices to
explore PNV use in women that receive WIC services. We piloted using a flyer
method in Rhode Island obstetrics and gynecology (OB/GYN) offices and Healthy
Babies and Mommies in North Kingstown, RI, to help recruit non-WIC participants,
but no one responded. Most of the non-WIC participants were recruited through
personal contact. Women were asked to complete a survey either in-person or online
with questions about PNV use, sociodemographic information, and food security.
Eleven WIC offices in RI were contacted for purposes of administering surveys to
WIC participants. Five different sites were willing to participate in the study. Every
WIC coordinator in the state of Rhode Island was given a brief overview of the study
and asked if they would be willing to have their office participate in the study. Five
WIC Coordinators responded and agreed to participate. The research assistant
personally recruited women in the waiting room of one WIC site in Providence, RI.
For the other four sites, onsite personnel recruited. These sites included Thundermist
WIC (Woonsocket, RI), Westerly WIC, Women and Infants WIC (Providence, RI),
and Children’s Friend WIC (Providence, RI). Recruitment was over once we reached
slightly above our goal sample size of 88 that was determined from the a priori power
5

equation. Once recruitment was over, the investigator picked up the completed surveys
at the four different sites. All WIC participants completed the paper survey.
Participants received a 5-dollar electronic Amazon gift card as an incentive.
Overall, 96 women were recruited. Thirty-one women filled out an online survey
and 65 women completed a paper survey. Participants were asked to review a consent
form in order to participate in the research study and we provided a copy for their
records. The survey was available in English and Spanish. The Spanish version was
translated by a professional translator from the Supplemental Nutrition Assistance
Program (SNAP). This project was approved by the Institutional Review Board on
August 16th, 2019. Recruitment took place August 18, 2019 through October 21, 2019.

Survey Development
The survey consisted of 21 questions that asked about the use of PNVs,
quality, barriers, socio-demographic characteristics, and food security (Appendix
D).10,11 Questions in the survey were developed by the study team, such as the number
of weeks pregnant, the use of PNVs, the frequency of PNVs, the brand of PNV, the
form of PNV, and whether or not the PNV is prescription or nonprescription. The
ideas for the questions were derived from studies that showed certain characteristics
are important when determining PNV use.1,2,6,8 A question was asked about the
motivators and barriers to PNV use since certain barriers seemed to be the main
concern of inadequate use of PNVs in previous studies.6 Two questions were
developed by the study team to measure participation in nutrition assistance programs
such as WIC and Supplement Nutrition Assistance Program (SNAP). All women that
6

were receiving SNAP benefits also received WIC benefits, so this question helped the
study team determine whether or not the participant is considered to be low-income if
they were participating in WIC. The sociodemographic questions were included in the
survey since previous studies showed discretion of MVI and PNV intake on
sociodemographic characteristics.6 The sociodemographic questions were taken from
an NIH study that involved a questionaiire.10 Race was self-reported from a list
including African American, native American, Asian/pacific islander, white, and
other. Ethnicity was self-reported as Hispanic or non-Hispanic. Lastly, there were two
questions about food security that have been validated from a study that identifies
families at risk for food insecurity.11
The survey was piloted with five women that are currently in WIC or
participated in WIC in the past. The women provided feedback on the survey to what
they understood and what needed clarification. From there, the survey was adjusted
accordingly. The online survey was developed using Qualtrics
(https://www.qualtrics.com).

Data analysis and Statistics
The independent variable in this study is reported WIC and non-WIC
participation. The dependent variable in this study is PNV use in pregnant women.
The sociodemographic characteristics being measured in this study include maternal
age in years, marital status, highest level of education, race, and ethnicity. The sample
was estimated using an A priori power analysis using the goodness-of-fit tests (x2) that
determined 88 participants were necessary to achieve 80% power. The final sample
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was comprised of 96 participants, exceeding the amount determined by the A priori
power analysis. We compiled descriptive statistics such as means and standard
deviation of variables. Pearson chi-square analyses were used to find differences
between WIC and non-WIC participants in PNV use and sociodemographic
characteristics. Statistical significance was set at p<0.05. Continuous variables in this
study were gestational age and maternal age. All other variables were categorical.
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RESULTS
Out of 96 pregnant women that participated in this study, 61% (n=59) of the
survey respondents were WIC participants and 39% (n=37) were non-WIC
participants. Characteristics of the participants, by WIC participation, are presented in
Table 1. There was a significant difference in race between WIC and non-WIC groups
(p<0.05). The distribution of race among non-WIC participants was predominately
white compared to WIC participants where there was a wide distribution between
races. A significant difference was found in ethnicity between WIC and non-WIC
groups (p<0.01). A higher percentage of WIC participants were Hispanic (47%)
compared to women that were Hispanic in the non-WIC sample (16%). Participants
also varied by education (p < 0.001), with a higher percentage of non-WIC
participants (59%) having a bachelor’s degree and the majority of WIC participants
having attained a high school diploma or GED (42%). There was a significant
difference in food security between WIC and non-WIC groups (p<0.01) with WIC
participants more likely to be food insecure than non-WIC groups. One question on
the survey stated “I was worried whether food would run out before I/we got money to
buy more. Was this often, sometimes, or never true for (you/your household in the last
12 months?”, and participants had to state whether this was often true, sometimes true
or never true. The percentage of WIC participants that stated “often true” or
“sometimes true” was 56%, indicating some level of food insecurity in that household.
The percentage of non-WIC participants that stated “often true” or “sometimes true”
was 27%. Another question asked, “The food (I/we) bought did not last and we did not
have money to buy more. Was this often, sometimes, or never true for (you/your
9

household) in the last 12 months?”. WIC Participants that reported “often true” or
“sometimes true” consisted of 49% of the WIC sample compared to 22% in the nonWIC sample. There was a significant difference between the groups for this food
insecurity question (p<0.01).
In terms of PNV use, 92% of women reported consuming PNVs during their
pregnancy and there were no statistically significant differences between WIC and
non-WIC participants. There were no differences in the frequency of PNV intake with
74% of participants out of the 88 participants that reported current use of PNVs,
reporting taking the vitamins between 5-7 times per week. There was a significant
difference in the type of PNV use (p<0.01), with more than half of the WIC
participants reporting using prescription PNVs, and far fewer (24%) of non-WIC
participants taking prescription PNVs.
Barriers to consumption of PNVs listed from both non-WIC and WIC groups
include difficulty remembering to take it, side effects such as nausea, vomiting,
general sickness, bad smell, and bad taste, and difficulty swallowing the pill.
In the survey, a question was asked “Who has recommended that you take
prenatal vitamins?” The majority of participants from both WIC and non-WIC groups
reported that a doctor recommend they take PNVs. However, some participants also
stated they received recommendations from a dietitian, friend, parent, or spouse.
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DISCUSSION
Overall, the majority of both WIC and non-WIC participants reported that they
were currently using of PNVs. Noting that almost all women from this convenience
sample in Rhode Island were taking PNVs, this suggests an improvement from studies
conducted one decade ago showing poor PNV use among certain populations
including low-income women.
Women participating in WIC were more likely to obtain prescription PNVs as
compared to non-WIC participants, which is a new finding in research. To further
investigate this result, the WIC sites used in this study were asked whether they
recommend that patients take a PNV during pregnancy despite the fact that PNV use is
not mentioned in the national WIC guidelines for nutrition education. We asked the
WIC coordinators at all four offices and they all had similar answers in that they ask
all moms if they are taking PNVs, and if they are not, they recommend they talk to
their primary care physician or obstetrician about taking them. According to a WIC
coordinator from Children’s Friend, because WIC participants are low-income, they
qualify for Medicaid, which covers PNVs throughout pregnancy. The WIC
coordinator confirmed that because women who participate in WIC generally qualify
for state medical insurance, the staff purposely refers them to their primary care
physician or obstetrician. According to feedback on what the staff reiterated to us, the
Nutrition Coordinator for the Rhode Island WIC program from the Rhode Island
Department of Health was contacted to gain more insight. Indeed, WIC sites in Rhode
Island have a policy regarding PNVs using their new computer system. The patients in
WIC programs are asked how many days per week they are taking a PNV and if they
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are receiving prenatal care. If a pregnant woman in the WIC program is at risk for
inadequate vitamin/mineral supplementation, they are marked at risk. Women in WIC
that meet this at-risk factor are encouraged to take PNVs, specifically ones that
contain iron, iodine, and folic acid.12
This emerging topic on prescription vs. non-prescription PNVs is interesting,
given that prescription and non-prescription PNVs have been found to differ in
micronutrient availability and composition.1,5 One study conducted from the Academy
of Nutrition and Dietetics in 2017 found a significant difference in prescription vs.
non-prescription PNVs. Prescription PNVs had fewer vitamins and minerals,
specifically vitamin A, vitamin D, iodine, and calcium.1 Just to note, the United States
does not have recommendations on the amount of vitamins and minerals in a prenatal
supplement.1 It is important to reach the recommended daily allowance for each
vitamin and mineral during pregnancy to reduce the risk of adverse birth outcomes,
but just because a prenatal supplement has more nutrients, it does not always mean it
is better.1 If taken in excess, some vitamins can be toxic to the body, but there is little
evidence on prenatal nutrition in pregnant women in the United States in general, so it
is difficult to determine if toxicity from prenatal supplements often occurs. One study
found did show that most women receive enough vitamin A through diet.13 If
consuming vitamin A through diet and taking a high dose of vitamin A through a
PNV, toxicity could occur and potentially lead to birth defects.14 On the other hand,
Vitamin D is important in PNVs since deficiency is common in the US, so it is
expected to be higher in PNVs. It would be interesting to know if health care providers
are aware of this discrepancy between prescription vs. non-prescription PNVs. Health
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care providers should be proactive about evaluating the use of supplements in
combination with diet and making the best recommendations for their patients that
would benefit both them and the baby.15
A strong association in race and ethnicity was shown between WIC and non-WIC
groups. however; PNV use did not vary by race or ethnicity in this present study.
Food security questions from this 21-question survey showed WIC participants
were more likely to be food insecure than non-WIC participants. This is not surprising
since the reason they qualify for this program is because they have a low-income.
Only 1 participant from WIC reported cost being a barrier to consuming PNVs,
and no participants from the non-WIC group reported cost being a barrier. This is
consistent with a study that looked at motivators and barriers to PNVs 1 decade ago.6
Interestingly enough, more WIC participants consumed gummy PNVs (20%)
compared to non-WIC (8%), although this variable in not significant.
There are some strengths to note in this study. To my knowledge, we are the first
to look at the question of PNV use between WIC and non-WIC participants. A
limitation to this study is that it was conducted in Rhode Island so it may not be
generalizable to other states. Pregnant women in RI have access to health care, which
may account for their higher than expected rates of prescription prenatal vitamin use.
States where low-income women may not have health care access might show
different results. This would be interesting to study for future research.
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CONCLUSION
This study shows a high intake of PNVs in WIC participants and non-WIC
participants, regardless of sociodemographic characteristics, but also shed light on the
amount of WIC women that acquire PNVs through a prescription. Because women
have access to prescriptions through health care, the significant uptake in PVN use
from 10 years ago could be a reflection on the increased availability of health care.
Obtaining prescription PNVs may also increase adherence to PNVs and increase
awareness of the importance of PNVs. Overall, health care providers should focus on
educating patients and providing the best resources to reach optimal vitamin and
mineral intake during pregnancy for both the health of the mother and the baby. 15 For
future research implications, it would be interesting to see research surrounding
micronutrient intake and diet quality in combination with PNV use.
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Table 1: Characteristics of WIC and Non-WIC Pregnant Women in Rhode
Island between August 2019 and October 2019
Characteristics

WIC Participation
n=59
Mean(SD) or n (%)

Non-WIC
Participation
n=37
Mean(SD) or n (%)

Pearson
ChiSquare

Maternal Age, yrs

25.9(5.1)

28.2(4.6)

0.1501

Gestational Age,
wks

22.9(8.7)

25.41(10.7)

0.3721

First Pregnancy

21 (36%)

15 (41%)

Race

12.070*

African American

6 (10%)

0 (0%)

Native American

2 (3%)

1 (3%)

Asian/Pacific
Islander

2 (3%)

0 (0%)

White

30 (51%)

32 (87%)

Other

11 (19%)

2 (5%)

Ethnicity

9.703**
Hispanic

28 (47%)

6 (16%)

Non-Hispanic

31 (53%)

31 (84%)

Marital Status

6.933

Married or domestic
partnership

23 (39%)

24 (65%)

Single, never
married

32 (56%)

11 (30%)

Other or No
response*

3 (5%)

2 (5%)

Education
No school
completed,
Or some high
school, no diploma

32.796***
12 (20%)

4 (11%)

17

High School
Diploma or
equivalent (GED)

25 (42%)

4 (11%)

Some college, no
degree or Associates
degree

17 (29%)

7 (19%)

Bachelor’s degree or
above

4 (7%)

22 (59%)

*p<0.05, ** p<0.01, ***p<0.001
1.

T-test used

2.

Other/no response category includes widowed, divorced, separated, other and no response
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Table 2: PNV use by WIC and Non-WIC Pregnant Women in Rhode Island
between August 2019 and October 2019
WIC
Participation
n=59
n (%)

Non-WIC
Participation
n=37
n (%)

Chi Square P Value

MVI use 3 months
prior to pregnancy

27 (56%)

18 (47%)

0.076

PNV Use

54 (92%)

34 (92%)

0.180

PNV use at any point
during pregnancy

57 (97%)

36 (97%)

0.105

Frequency of PNV
use

2.966

(1-4x/wk)

10/59 (17%)

3 (8%)

(5-7x/wk)

36 (61%)

29 (78%)

4 (7%)

1 (3%)

(More than 7x/wk)
Form of PNV

3.193

Pill

39 (66%)

30 (81%)

Chewable

3 (5%)

1 (3%)

Gummy

12 (20%)

3 (8%)

Prescribed

11.715**
Yes

31 (53%)

9 (24%)

No

20 (34%)

25 (68%)

3 (5%)

0 (0%)

Unsure
**p<0.01
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Table 3: Food Security by WIC and Non-WIC Pregnant Women in Rhode Island
between August 2019 and October 2019
Question 1: “I was worried whether food would run out before I/we got money to buy
more. Was this often, sometimes, or never true for (you/your household in the last 12
months?”
Question 2: “The food (I/we) bought did not last and we did not have money to buy
more. Was this often, sometimes, or never true for (you/your household) in the last 12
months?

WIC
Participation
n=59
n (%)

Non-WIC
Participation
n=37
n (%)

Food Security Q1

Pearson
Chi Square

10.658**

Often True

10 (17%)

0 (0%)

Sometimes true

23 (39%)

10 (27%)

Never true

26 (44%)

27 (73%)

Food Security Q2

8.980*

Often True

7 (12%)

0 (0%)

Sometimes true

22 (37%)

8 (22%)

Never true

30 (51%)

29 (78%)

*p<0.05, ** p<0.01, ***p<0.001
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Appendix A: REVIEW OF LITERATURE
Introduction
Use of prenatal vitamins (PNVs) in pregnant women can improve maternal
nutrition status and decrease the risk of adverse birth outcomes such as preterm birth,
low birth weight, long-term cognitive development, cardio-metabolic disease, and
potential mortality.1–3Therefore, clinicians recommend PNVs to meet micronutrient
requirements during pregnancy.4
PNVs are a combination of vitamins and minerals that help facilitate the process
of receiving adequate nutrition during pregnancy.5 Some populations may be at risk
for poor PNV use. Previous studies conducted about 1 decade ago show poor PNV use
in low income women, African American women, and Hispanic women compared to
higher income women and white women.6,7 Other studies showed that PNV use was
higher in women who have higher education levels and also higher in women that are
married or in a domestic partnership compared to single or divorced women.6
The Special Supplemental Nutrition Program for Women, Infants, and Children
(WIC) is a federally funded supplemental nutrition program for low-income,
nutritionally at-risk pregnant women, breastfeeding women, and non-breastfeeding
postpartum women.8\ This program is available in all 50 states. The women in this
program receive nutrition education, supplemental foods, and information on the
benefits of breastfeeding promotion and support, and other referrals to optimize health
care. In order to participate in this program, there is a strict income eligibility
requirement based on the number of participants in the household and annual,
monthly, twice-monthly, and bi-weekly incomes. These women receive nutrition
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education, but they are not prescribed PNV through WIC. Interestingly enough, there
are no studies conducted on PNV use in WIC participants. We are interested in seeing
the prevalence of women consuming any type of PNV during pregnancy and if they
differ between women participating in WIC and women not participating in WIC in
the state of Rhode Island.
The Rhode Island Department of Health (DOH) conducts surveys every year
called the Pregnancy Risk Assessment Monitoring System (PRAMS) that determine
daily multivitamin (MVI) use 1 month prior to pregnancy.9 The survey asks how many
times women take a MVI, PNV, or folic acid supplement the month before they
conceived, while also measuring sociodemographic characteristics and if they
participate in WIC. They found that in 2015, 36.8% of women took a daily MVI one
month prior to pregnancy. The data showed mothers that were older than 30 years old,
white (non-Hispanic), married, has 12 or more years of education, has private health
insurance, and did not participate in WIC were more likely to take a MVI one month
prior to pregnancy.9 Although Rhode Island collects this information and formulates
the data on these pregnant women that live in Rhode Island, they do not measure
actual prenatal vitamin use during pregnancy.
It is important to look at the comparison between WIC and non-WIC
populations in Rhode Island since PRAM studies found a difference in MVI/PNV use
one month prior to pregnancy between women that participate in WIC and women that
do not participate in WIC. We are exploring if WIC women are still less likely to
consume PNVs during pregnancy than non-WIC women. Because WIC women are
classified as having a low income, they may not be able to afford PNVs which would
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also be consistent with previous research showing that low-income women are less
likely to consume PNVs. By potentially identifying low-income women who are
unable to obtain PNVs due to cost, communities and physicians could provide or
supplement PNVs to help women meet their daily micronutrient requirements during
pregnancy.
The objective of this cross-sectional study was to assess the prevalence of PNV
intake based on a sample of pregnant WIC and non-WIC women in the state of Rhode
Island and explore if WIC participants ability to buy PNVs is impacted due to their
low socioeconomic status. We hypothesized that women participating in WIC were
less likely to consume PNV compared to women that do not participate in WIC.

Micronutrient Deficiencies in Pregnancy
Micronutrients are vitamins and minerals that are necessary in the human body
for proper functioning, growth and development.16 Multiple micronutrient deficiencies
exist in pregnant women globally, leading to adverse maternal and infant outcomes.1,16
These deficiencies are a form of undernutrition among pregnant women and many
major risk factors are associated with deficiencies including preeclampsia, preterm
delivery, poor placenta function, gestational diabetes, and low birth weight babies.14,17
Micronutrients are essential during pregnancy to assist in cellular metabolism, provide
optimal tissue function and growth, and be involved in enzyme and hormone
production.14 Groth’s research found that adequate micronutrient intake is critical for
fetal development, positive pregnancy outcomes, prevention of birth defects, preterm
birth, and neural tube defects.4
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Deficiencies in micronutrients such as folate, iron, zinc, vitamins A, B6, B12, C,
E and riboflavin are highly prevalent among pregnant women.2 For example,
according to data reviewed in the 2015-2020 Dietary Guidelines for Americans,
dietary intakes from food alone among pregnant women was 24% below the Estimated
Average Requirement (EAR) for calcium, 26% below for vitamin A, 29% for folate,
30% for vitamin C, 90% for vitamin D, 94% for vitamin E, and 96% for iron.1 One
study in Hackney, London showed that 78% of women that gave birth to a low birth
weight baby had poor nutrition, and inadequate consumption of micronutrients, only
meeting less than 4 of 16 dietary reference intake values.17
There are many reasons why certain micronutrients are needed during
pregnancy, as it plays a role in the physiological change in the body, decreases risk for
adverse birth outcomes, and impacts long-term cognitive and mental development in
the offspring.18 Some primary nutrients include: iron, iodine, selenium, zinc, folate,
vitamin D, and vitamin A. Iron is an extremely common micronutrient deficiency
among pregnant women, and is needed to support fetal development and anemia risk
with advanced gestation.14 Iodine deficiency during pregnancy is the number one
preventable cause of brain damage and mental retardation in newborns and is
important for synthesizing thyroid hormones during pregnancy.14 Maternal selenium
deficiency can lead to miscarriage, preeclampsia, intrauterine growth restriction
(IUGR), and preterm birth. Selenium deficiency during pregnancy can also create
disorders in the infant including cardiac myopathy, muscular dystrophy, impaired
thyroid metabolism, and abnormal neurological disorders. Zinc is involved in
carbohydrate metabolism, protein metabolism, nucleic acid synthesis, and cell
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differentiation. Folate deficiency during pregnancy can cause congenital
malformations such as neural tube defects (NTD).14 Pregnant women with maternal
vitamin D deficiency can lead to poor fetal brain development, diabetes, fetal
hypocalcemia and rickets in a newborn.17 Vitamin A assists in lung function and
deficiency can lead to broncho-pulmonary diseases in a newborn. Overall, each
micronutrient contributes to positive health for both the mother and the baby.

Populations at risk for micronutrient deficiencies
Although micronutrients are critical for fetal development, there are some
populations that are at risk for micronutrient deficiencies and inadequate intake of
PNVs according to prior research studies. The populations at risk for poor supplement
use include low income women and certain races or ethnicities.6,7 In a study measuring
diet quality among low-income pregnant Hispanic women, diet quality was
suboptimal, and women were not meeting the recommended 2015-2020 Dietary
Guidelines for Americans, with apparent disparities between race, ethnicity, and
socioeconomic status.19
Women with a low socioeconomic status tend to have adverse birth outcomes
such as preterm birth and low-birthweight babies compared to women with a higher
socioeconomic status with one of the factors relating to poor nutritional intake and
poor access to prenatal care.18 One study conducted shed light on income affecting
prenatal nutrition and birth outcomes overall. This research showed that low-income
women that received 64 supplemental dollars per month in the 2nd and 3rd trimester
through a program called “The Healthy Baby Prenatal Benefit” were less likely to
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have low birth weight babies and preterm births.18 The group that did not receive the
supplemental dollars had more adverse birth outcomes such as preterm birth and low
birth weight babies. The research believes that women who were supplemented with
money each month were more likely to afford prenatal nutrition care, although what
the women did with the supplemental dollars was not measured.18 Although this article
does not discuss prenatal vitamins, women with the supplemental dollars could have
used that money to buy PNVs and obtain the appropriate micronutrient amounts their
body needs for a healthy pregnancy.

PNV use and populations at risk for poor intake
PNVs contain vitamins and minerals that are tailored to fit the increased needs of
the pregnant population due to the rapid physiological change that occurs in
pregnancy.13 PNV supplementation allows women to compensate for any nutrients
that may be low or missing in their diet, given that micronutrient requirements during
pregnancy are increased.
Masho and colleagues conducted a study investigating multivitamin use one month
prior to pregnancy.7 This study found that more than half of women (55%) did not
take any multivitamin (MVI) pre-pregnancy and only 30% of women showed a daily
intake of MVI pre-pregnancy. From this data, Masho divided these intakes between
demographic subgroups and found that MVI intake was strongly associated with
socio-demographic characteristics of the women such as marital status, income, race,
age, and ethnicity.7 This study shows that there is a significant difference associated
with sociodemographic characteristics including socioeconomic status.
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In 2009, Tessema and colleagues found that 52% of non-Hispanic black
women were inconsistent users of PNVs and 52% of Hispanic women were
inconsistent users, showing that more than half of these populations report inadequate
use of PNVs.6 However, no further research has been conducted since 2009 regarding
PNV use comparing demographic subgroups. Given this knowledge gap in literature,
secondary evaluation of PNV use across racial and ethnic subgroups shed light on how
disparity has changed over the last decade.
Consistent with research showing low income women are more likely to have
poor maternal nutrition, studies have shown that socioeconomic status is a factor in
consuming PNV.6 Low-income women are more likely to be inconsistent users of
PNVs than higher income women. Women with an income of less than $25,000 per
year were at a high risk for inconsistent PNV use, more specifically, 68% of women
reported inconsistent use. With women who had a household income of $25,000 $50,000, only 43% were inconsistent users, a 24% difference between the two income
categories.6
One study conducted in 2011 showed that women who take supplemental
vitamins and minerals in the form of a MVI showed a reduced risk in adverse birth
outcomes such as preterm birth and fetal growth restriction.3 In this study, only 60.7%
of women reported PNV use. Of those 60.7%, they were more likely to have a low
socio-occupational status meaning that they were unemployed or unskilled workers.
This study also showed periconceptional multivitamin use was associated with
reduced risk of preterm birth and more prominently, small for gestational age.3
Another study conducted in 2013 showed MVI use during pregnancy reduces the

27

incidence of small for gestational age infants specifically in low-income women,
suggesting that that income plays a role in PNV consumption.13

Prescription vs. Nonprescription PNVs
PNVs differ between prescription and non-prescription products in
composition and dosing of nutrients.1 A study conducted in 2016 looked the labeling
content to determine the difference between prescription and nonprescription prenatal
supplements. Prescription products had less vitamins and minerals compared to
nonprescription products including Vitamin A, vitamin D, iodine, and calcium.
However, they did find that folic acid was higher in prescription products, and iron,
zinc, and DHA were very similar in both prescription and nonprescription. In addition,
nonprescription PNVs contained more botanical ingredients and probiotics.
Interestingly enough, 17% of prescription PNVs contained a stool softener, while
nonprescription PNVs did not. Overall, health care providers should be focusing on
the patients diet to determine the appropriate PNV to ensure the patient is obtaining
the correct nutrient amount in their body.1
Special Supplemental Nutrition Program for Women, Infants, and Children
Federal food assistance programs such as the Supplemental Nutrition Program
for Women, Infants, and Children, are an important source of healthy food for lowincome populations.8 WIC is a national public health nutrition program that
supplements nutritious foods, provides nutrition education and counseling, and
screening and referrals to other health, welfare, and social services.6 The target
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population at WIC is low-income, nutritionally at-risk pregnant women, breastfeeding
women, non-breastfeeding postpartum women (up to 6 months after birth of infant),
infants up to first birthday, and children up to their 5th birthday. The goal of WIC
nutrition education services is to strengthen nutrition education, adopt a more
behavioral approach to nutrition education, be client oriented, and focus on healthy
behaviors for life.8 Although nutrition education is delivered at WIC appointments,
PNVs are not supplemented. Updated on January 25th, 2017, the federal guidelines for
nutritional education for WIC specifically states that nutrition education is to assist the
individual who is at nutritional risk in achieving a positive change in dietary and
physical activity habits resulting in improved nutritional status and in the prevention
of nutrition-related problems through optimal use of the WIC supplemental foods and
other nutritious foods.20 The goal for WIC is to educate in obtaining a healthy diet
through nutritious foods rather than offering PNVs to supplement the missing
micronutrients in their diet. WIC offices typically do not supplement PNVs or offer
them in their clinic. There is data lacking on PNV use in WIC participants.
Understanding if women that participate in WIC are at a high risk for poor use of PNV
can help the program strive to perform maximum education or budget ways to include
PNVs to distribute to the women who participate in WIC.
Barriers to Prenatal Vitamin Intake
Common barriers to women consuming PNVs include adverse effects, poor
communication from health care providers, skepticism toward the benefits, busy
lifestyle, non-adherence, and bad taste.6 Descriptions of adverse side effects of bad
taste include gagging, nausea, emesis, general sickness, constipation.6 In a study of
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non-Hispanic black women, many women expressed reluctance to take medicines
prophylactically or said they experience difficulty taking any pills and requested the
pill be in an alternate form such as liquid, patch, injection, shake/smoothie, or a
sweetened, chewable pill.6 Lastly, many that reported poor use of PNVs had limited
understanding of the purpose of vitamins and minerals in PNVs and how they relate to
the development and growth of the fetus.6 Therefore, there should be more
communication from health care providers about the positive impact of PNV use
during pregnancy.
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Appendix B

The University of Rhode
Island
Research Study

Are you interested in receiving a

$5.00 Amazon Gift Card?
Are you currently pregnant and at
least 18 years old?
Dr. Brietta Oaks and Allisa Georgio
would like you
to participate in a survey about
prenatal vitamin intake in pregnant women.
The survey will only take 5-10 minutes of your
time.
If you are interested,
please email
Allisa Georgio at

Allisa_Georgio@my.uri.edu
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This
research has been
approved by the
University of Rhode
Island Institutional
Review Board.

APPENDIX C
IRB
Exempt Consent
Dr.Brietta Oaks
Nutrition and Food Sciences
Examining the use of prenatal vitamins according to Women, Infants, and Children (WIC) participation.

You are being asked to take part in a research study. The purpose of the research study
is to examine the use of prenatal vitamins among pregnant women in Rhode Island.
Please read the following before agreeing to be in the study. If you agree to be in this
study, it will take you approximately 5-10 minutes to complete this survey. Questions
will be asked about prenatal vitamin use, sociodemographic characteristics, and food
security. There are no known risks to participating in this study. You will be
compensated with a 5-dollar Amazon gift card for participating in this study.
Your responses will be strictly anonymous. The responses may be used in a research
paper.
The decision to participate in this study is entirely up to you. You may refuse to take
part in the study at any time without affecting your relationship with the investigators
of this study or the University of Rhode Island (URI). Your decision will not result in
any loss of benefits to which you are otherwise entitled. You have the right not to
answer any single question, as well as to withdraw completely from the survey at any
point during the process; additionally, you have the right to request that the
researchers not use any of your responses.
You have the right to ask questions about this research study and to have those
questions answered by me before, during or after the research. If you have questions
about the study, at any time feel free to contact Dr. Brietta Oaks from the Department
of Nutrition and Food Sciences at the University of Rhode Island (URI) at 401-8744021.
Additionally, you may contact the URI Institutional Review Board (IRB) if you have
questions regarding your rights as a research participant. Also contact the IRB if you
have questions, complaints or concerns which you do not feel you can discuss with the
investigator. The University of Rhode Island IRB may be reached by phone at (401)
874-4328 or by e-mail at researchintegrity@etal.uri.edu. You may also contact the
URI Vice President for Research and Economic Development by phone at (401) 8744576.
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Keep a copy of this document for your records. You may also contact the researcher
to request a copy. By completing the survey, you indicate that you have read and
understood the above and volunteer to participate in this study.
APPENDIX D
Research Survey
Congratulations on your pregnancy and thank you for agreeing to participate in this
survey. We are interested in learning a little bit more about you and your diet
during pregnancy. Please answer all of the questions to the best of your ability.
Answer a question by circling the correct answer. If you do not know the answer
to a question, or would preferer not to answer, please just skip to the next question.
Thank you.
How many weeks pregnant are you?
_______
Is this your first pregnancy?
Yes
No
Were you taking any multivitamins or prenatal vitamins in the 3 months prior to your
pregnancy?
Yes
No
Unsure
Have you taken a prenatal vitamin at any point during this pregnancy?
Yes
No
Unsure
Are you currently taking any prenatal vitamins?
Yes
No
Unsure
If you answered no to question number 5, please skip to question number 10. If you
answered yes to question number 5, please answer the questions below.
6. How often do you take prenatal vitamins?
a. 1 to 4 times per week
b. 5 to 7 times per week
c. More than 7 times per week
d. Other ________
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7. What is the brand name of your prenatal vitamin? (Some common
brands include NatureMade, One A day, CVS, PreNatal, Vitafusion,
Alive!)
a.________________
8. In what form do you take your prenatal vitamin?
a. Pill
b. Chewable
c. Gummy
d. Other
9. Is your prenatal vitamin prescription or non-prescription?
a. Prescription
b. Non-Prescription
c. I am unsure if my prenatal vitamin is prescription or nonprescription
10. If you do not take a prenatal vitamin, what is the reason for it? (Check all that
apply)
a. Cost
b. Side effects such as nausea, vomiting, or general sickness
c. Difficulty swallowing the pill
d. Bad taste
e. Bad smell
f. Difficulty remembering to take it
g. Other _____________________
11. Are you currently participating in the Women, Infants, and Children (WIC)
program?
a. Yes
b. No
12. Are you currently participating in the Supplemental Nutrition Assistance Program
(SNAP)?
a. Yes
b. No
13. Has anyone recommended that you take prenatal vitamins?
a. Yes
b. No
14. If yes, who has recommended that you take prenatal vitamins?
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a.
b.
c.
d.
e.
f.

Doctor
Dietitian or Nutritionist
Friend
Parent
Spouse
Other _______

Please answer the following questions regarding socio-demographic characteristics.
15. Are you Hispanic Or Latino?
a. Yes
b. No
16. Please specify your race.
a. African American
b. Native American
c. Asian / Pacific Islander
d. White
e. Other _________
17. How old are you?
a. _________
18. What is your marital status?
a. Married or domestic partnership
b. Widowed
c. Divorced
d. Single, never married
e. Separated
f. Other
19. What is the highest degree or level of school you have completed?
a. No school completed
b. Some high school, no diploma
c. High school diploma or equivalent (for example: GED)
d. Some college, no degree
e. Associate degree
f. Bachelor’s degree
g. Master’s degree or above
Please read the questions below and specify often true, sometimes true, or
never true.
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20. I was worried whether food would run out before (I/we) got money to buy more.
Was this often, sometimes, or never true for (you/your household) in the last 12
months?
a. Often true
b. Sometimes true
c. Never true
21. The food (I/we) bought did not last and we did not have money to buy more. Was
this often, sometimes, or never true for (you/your household) in the last 12
months?
a. Often true
b. Sometimes true
c. Never true
Thank you for your time.
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APPENDIX E

IRB
Exempt Consent
Spanish Version
Dr.Brietta Oaks
Nutrition and Food Sciences
Examining the use of prenatal vitamins according to Women, Infants, and Children (WIC) participation.

Se le está pidiendo participar en un estudio de investigación. El propósito de este estudio de
investigación es examinar el uso de vitaminas prenatales entre mujeres embarazas en Rhode
Island. Por favor lea lo siguiente antes de aceptar estar en el estudio. Si acepta estar en este
estudio, le tomará aproximadamente 5-10 minutos para completar esta encuesta. Se le harán
preguntas sobre el uso de vitaminas prenatales, características sociodemográficas y seguridad
alimentaria. No hay riesgos conocidos por participar en este estudio. Se le compensará con
una tarjeta de regalo de 5 dólares de Amazon por participar en este estudio.
Sus respuestas serán estrictamente anónimas. Las respuestas pueden ser utilizadas en un
trabajo de investigación.
La decisión de participar en este estudio es totalmente suya. Usted puede reusarse a tomar
parte en el estudio en cualquier momento sin afectar su relación con los investigadores de este
estudio o la Universidad de Rhode Island (URI). Su decisión no resultará en la perdida de los
beneficios a los que usted tiene derecho. Tiene el derecho de no responder cualquier pregunta,
así como de retirarse por completo de la encuesta a cualquier momento durante el proceso;
además, tiene el derecho a solicitar que los investigadores no utilicen ninguna de sus
respuestas.
Usted tiene el derecho de hacer preguntas sobre este estudio de investigación y de que yo las
responda antes, durante o después de la investigación. Si tiene preguntas sobre el estudio, no
dude en contactar en cualquier momento a Brietta Oaks del Departamento de Nutrición y
Ciencia de los Alimentos en la Universidad de Rhode Island (URI) al 401-874-4021.
Adicionalmente, puede comunicarse con la Junta de Revisión Institucional de URI (URI
Institutional Review Board (IRB)) si usted tiene preguntas sobre sus derechos como
participante. También comuníquese con el IRB si tiene preguntas, quejas o inquietudes de las
cuales considere que no pueda discutir con el investigador. Puede comunicarse con el IRB de
la Universidad de Rhode Island por teléfono al (401) 874-4328 o por correo electrónico (email) al researchintegrity@etal.uri.edu. También puede comunicarse con el Vicepresidente de
Investigación y Desarrollo Económico de URI por teléfono al (401) 874-4576.
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Ejemplo 1 (Encuesta anónima en línea): Si desea conservar una copia de este documente
para sus registros, por favor imprima o guarde esta página ahora mismo. También puede
comunicarse con la investigadora para solicitar una copia.
Al darle clic a continuación para ser llevada a la encuesta, usted ha indicado que ha leído y
comprendido lo anterior y se ofrece como voluntario para participar en este estudio.
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APPENDIX F
Encuesta de Investigación
Felicidades por su embarazo y gracias por aceptar participar en esta encuesta. Estamos
interesados en conocer un poco más sobre usted y su dieta durante el embarazo.
Por favor responda a todas las preguntas lo mejor que pueda. Responda cada
pregunta circulando la respuesta correcta. Si no sabe la respuesta a una pregunta, o
prefiere no contestar, por favor solo salte a la siguiente pregunta. Gracias.
1. ¿Cuántas semanas de embarazo tiene?
_______
2. ¿Este es su primer embarazo?
Sí
No
3. ¿Estuvo tomando algún multivitamínico o vitaminas prenatales en los 3
meses previos a su embarazo?
a. Sí
b. No
c. No estoy segura
4. ¿Ha tomado vitaminas prenatales en algún punto durante este embarazo?
a. Sí
b. No
c. No estoy segura
5. ¿Actualmente está tomando algunas vitaminas prenatales?
a. Sí
b. No
c. No estoy segura
Si contestó que no a la pregunta número 5, por favor salte a la pregunta número 10.
Si contesto que sí a la pregunta número 5, por favor conteste las siguientes
preguntas.
6. ¿Con que frecuencia toma vitaminas prenatales?
d. 1 a 4 veces a la semana
e. 5 a 7 veces a la semana
f. Más de 7 veces a la semana
g. Otra ________
7. ¿Cuál es la marca de sus vitaminas prenatales? (Algunas marcas comunes
incluyen NatureMade, One A day, CVS, PreNatal, Vitafusion, Alive!)
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a.________________
8. ¿En qué forma toma sus vitaminas prenatales?
a. Píldora
b. Masticable
c. Gomita
d. Otra
9. ¿Sus vitaminas prenatales son de prescripción o sin prescripción?
a. Prescripción
b. Sin prescripción
c. No estoy segura si mis vitaminas prenatales son de prescripción o
sin prescripción
10. ¿Si no toma vitaminas prenatales, cual es la razón? (Marque todas las que
apliquen)
a. Costo
b. Efectos secundarios como náusea, vómito o mal estado general
c. Dificultad para tragar la píldora
d. Mal sabor
e. Mal olor
f. Dificultad para recordar tomarla
g. Otra _____________________
11. ¿Está actualmente participando en el programa de Women, Infants, and
Children (WIC)?
a. Sí
b. No
12. ¿Está actualmente participando en el programa Supplemental Nutrition
Assistance Program (SNAP)?
a. Sí
b. No
13. ¿Alguien le ha recomendado tomar vitaminas prenatales?
a. Sí
b. No
14. Si la respuesta es sí, ¿quién le ha recomendado tomar vitaminas prenatales?
a. Doctor
b. Dietista o Nutricionista
c. Amiga/o
d. Madre/Padre
e. Pareja
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f. Otro _______
Por favor responda las siguientes preguntas respecto a características
sociodemográficas.
15. ¿Es usted Hispana o Latina?
a. Sí
b. No
16. Por favor especifique su raza.
a. Afroamericano
b. Americano Nativo
c. Asiático / Isleño Pacífico
d. Blanco
e. Otro _________
17. ¿Qué edad tiene?
a. _________
18. ¿Cuál es su estado marital?
a. Casada o asociación doméstica
b. Viuda
c. Divorciada
d. Soltera, nunca casada
e. Separada
f. Otro
19. ¿Cuál es su título o nivel de escuela más alto que ha completado?
a. Sin escuela completa
b. Algo de preparatoria, sin diploma
c. Diploma de escuela preparatoria/secundaria o equivalente (por
ejemplo: GED)
d. Algo de universidad, sin titulo
e. Título de preparación universitaria básica/título de asociado
f. Licenciatura
g. Maestría o más alto
Por favor lea las siguientes preguntas y especifique si es a menudo cierto, a
veces cierto o nunca cierto.
20. Estaba preocupada de que se acabara la comida antes de que
(yo/nosotros) tuviéramos dinero para comprar más. ¿Era esto a menudo, a
veces o nunca cierto para (usted/su casa) en los últimos 12 meses?
a. A menudo cierto
b. A veces cierto
c. Nunca cierto
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21. Los alimentos que (yo/nosotros) compramos no duraron mucho tiempo y
no tuvimos dinero para comprar más. ¿Era esto a menudo, a veces o nunca
cierto para (usted/su casa) en los últimos 12 meses?
a. A menudo cierto
b. A veces cierto
c. Nunca cierto
Gracias por su tiempo.
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